SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREG FINLEY who wrote (391)6/25/1999 7:58:00 AM
From: geewiz  Read Replies (1) of 534
 
Greg,

This news item won't help any;

Elan shares tumble as bid speculation fades

DUBLIN, June 25 (Reuters) - Shares in Irish pharmaceutical group Elan Corp (NYSE:ELN - news)(quote from Yahoo! UK & Ireland: ELA.L) were sharply lower on Friday as its Dublin and London listings tracked the U.S. share down as recent takeover speculation faded, dealers said.

Elan shares were down 11.4 percent in Dublin at 27.81 euros, helping pull the ISEQ index of leading Irish shares down more than two percent. In London, the stock was off five percent at 19.00 pounds sterling. In New York overnight the shares closed at $29, down $2-15/16.

Elan shares, which have come under pressure amid worries about the group's product pipeline

later, art
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext